These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6861179)

  • 21. [Malignant lymphoma. Experiences with autologous bone marrow transplantation in 50 patients].
    Hagberg H; Berglund A; Carlson K; Glimelius B; Höglund M; Lönnerholm G; Martinsson U; Simonsson B; Smedmyr B; Oberg G
    Lakartidningen; 1993 Nov; 90(45):3950-3. PubMed ID: 8231566
    [No Abstract]   [Full Text] [Related]  

  • 22. Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
    Constine LS; Wolkov HB; Yahalom J; Mauch PM; Deming RL; Dosoretz DE; Elman AJ; Hoppe RT; Pistenmaa DA; Prosnitz LR; Chauvenet A; Connors JM; Glick JH; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1225-56. PubMed ID: 11037544
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prognostic factors and their importance in the modification of therapeutic approaches in patients with Hodgkin's disease].
    Vernerová E; Tesarová P; Hermanská Z; Dienstbier Z; Chytrý P
    Cas Lek Cesk; 1993 May; 132(9):266-9. PubMed ID: 8513472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
    Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience.
    Sperotto A; Zaja F; Damiani D; Patriarca F; Fanin R
    Haematologica; 2001 Dec; 86(12):1317-8. PubMed ID: 11726327
    [No Abstract]   [Full Text] [Related]  

  • 27. Epithelioid granulomas in Hodgkin's disease--prognostic significance.
    Chopra R; Rana R; Zachariah A; Mahajan MK; Prabhakar BR
    Indian J Pathol Microbiol; 1995 Oct; 38(4):427-33. PubMed ID: 9726157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the localization of malignant lymphogranuloma in the pulmonary parenchyma].
    Anaveri G
    Nunt Radiol; 1966 Jul; 32(7):677-99. PubMed ID: 5990331
    [No Abstract]   [Full Text] [Related]  

  • 29. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
    Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
    Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of various factors on the survival period in Hodgkin's disease].
    Gabryś K; Sciborski R; Gałazka Z; Smakowska E; Kotlarek-Haus S
    Pol Tyg Lek; 1982 Jul; 37(24-25):713-5. PubMed ID: 7177968
    [No Abstract]   [Full Text] [Related]  

  • 31. [Primarily detected lymphogranulomatosis].
    Ardashev VN; Kizhaev EV; Zav'ialov MS
    Voen Med Zh; 2000 Feb; 321(2):41-8. PubMed ID: 10870447
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the problem of the clinico-morphological peculiarities of a protracted form of lymphogranulomatosis].
    Ignat'eva IA
    Sov Med; 1966 Apr; 29(4):30-4. PubMed ID: 5984036
    [No Abstract]   [Full Text] [Related]  

  • 33. Interrelationship between several prognostic factors in Hodgkin's disease.
    Kotlarek-Haus S; Gabryś K; Starzyk H; Sciborski R; Gałazka Z
    Arch Geschwulstforsch; 1982; 52(4):293-301. PubMed ID: 7138241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinico-pathological study of Hodgkin's lymphoma in a cancer center in Taiwan.
    Lee MY; Tan TD; Feng AC
    Clin Lab Haematol; 2005 Dec; 27(6):379-83. PubMed ID: 16307539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant lymphogranuloma with specific cutaneous elements. 2 cases].
    de Dulanto F; Armijo Moreno M; Narano Sintes R; Camacho Martínez F; de Cosme Jiménez L
    Actas Dermosifiliogr; 1975; 66(9-10):451-70. PubMed ID: 1199819
    [No Abstract]   [Full Text] [Related]  

  • 37. Hodgkin disease in ataxia-telangiectasia patients with poor outcomes.
    Sandoval C; Swift M
    Med Pediatr Oncol; 2003 Mar; 40(3):162-6. PubMed ID: 12518345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
    Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
    Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
    Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
    Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On an unusual course of lymphogranulomatosis].
    Heuck F; Piepgras U
    Strahlentherapie Sonderb; 1969; 69():119-25. PubMed ID: 5778899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.